VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an ...

The global psoriasis therapeutics market revenue was around US$ 25.0 billion in 2022 and is estimated to reach US$ 55.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.3% during ...

The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.

Oruka Therapeutics (ORKA) has received a new Buy rating, initiated by Leerink Partners analyst, David Risinger. David Risinger has given his ...

Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including ...

Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis.

Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...

Know 5 unusual signs of nail psoriasis you shouldn't ignore. Learn how to identify this condition early and take steps to ...

The relationship between psoriasis and social anxiety highlights the intricate connection between physical and mental health.

Image Credit: Maria Pilar/Shutterstock.com Psoriasis is a chronic autoimmune skin condition that causes the rapid buildup of ...

The overactive immune response in psoriasis can influence your brain’s chemicals, which can lead to both depression and ...

Prof. Adam Reich reviewed itch in psoriasis, while Dr. Anushka Irani discussed the connection between pain and psoriatic ...